clevidipine has been researched along with dihydropyridines in 7 studies
| Studies (clevidipine) | Trials (clevidipine) | Recent Studies (post-2010) (clevidipine) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 127 | 19 | 62 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonon, A; Nordlander, M; Rydén, L; Segawa, D; Sjöquist, PO; Wang, QD | 1 |
| Gyllenhaal, O | 1 |
| Blanchard, AP; Chandler, C; Clark, RJ; Crespi, CL; Dehal, SS; Ho, T; Johnson, J; Stresser, DM; Wong, J; Zhang, JG | 1 |
| Dunbar, L; Ebrahimi, R; Frank Peacock, W; Pollack, CV; Varon, J | 1 |
| Hu, MY; Komjathy, SF; Marbury, TC; Mould, DR; Smith, WB; Sumeray, MS; Williams, GC | 1 |
| Chen, H; He, X; Jia, M; Li, H; Li, W; Ni, Y; Xu, M; Zhou, Y | 1 |
| Ding, L; Li, Q; Li, T; Sun, L; Wang, Y; Yang, W; Zhao, L | 1 |
2 trial(s) available for clevidipine and dihydropyridines
| Article | Year |
|---|---|
Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Dihydropyridines; Humans; Hypertension; Infusions, Intravenous; Kidney; Male; Middle Aged; Pyridines; Severity of Illness Index; Treatment Outcome | 2011 |
Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Half-Life; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Pyridines; Single-Blind Method | 2012 |
5 other study(ies) available for clevidipine and dihydropyridines
| Article | Year |
|---|---|
Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine.
Topics: Animals; Calcium Channel Blockers; Cardiotonic Agents; Coronary Circulation; Dihydropyridines; Heart Atria; Heart Block; Heart Rate; Isradipine; Male; Myocardial Contraction; Nifedipine; Pyridines; Rats; Rats, Sprague-Dawley; Systole; Ventricular Function, Left; Ventricular Pressure | 1999 |
Fast enantioselective separation of clevidipine and a dihydropyridine substituted acid by SFC on Chiralpak AD.
Topics: Calcium Channel Blockers; Dihydropyridines; Hydrolysis; Pyridines; Solvents; Spectrophotometry, Ultraviolet; Stereoisomerism | 2001 |
Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81.
Topics: Calcium Channel Blockers; Cells, Cultured; Child; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; DNA, Complementary; Drug Interactions; Enzyme Inhibitors; Female; Hepatocytes; Humans; Isoenzymes; Male; Middle Aged; Pyridines | 2006 |
Simultaneous determination of clevidipine and its primary metabolite in dog plasma by liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic study.
Topics: Animals; Antihypertensive Agents; Biotransformation; Calibration; Chromatography, Liquid; Dihydropyridines; Dogs; Infusions, Intravenous; Limit of Detection; Linear Models; Pyridines; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats.
Topics: Animals; Chromatography, Liquid; Dihydropyridines; Female; Injections, Intravenous; Linear Models; Liver; Male; Myocardium; Pyridines; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2018 |